• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGMR313120J
Device Problem No Apparent Adverse Event (3189)
Patient Problem Pseudoaneurysm (2605)
Event Date 09/13/2022
Event Type  Death  
Manufacturer Narrative
Code "other" was selected as the medical device remains implanted.Return not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
On (b)(6) 2021, a patient underwent endovascular treatment of a thoracic aortic disease using gore® tag® conformable thoracic stent graft with active control system (ctagac) #tgm343420j.The patient had already undergone a total arch replacement and a frozen elephant trunk.The ctagac was implanted to extend distally from the elephant trunk.On unknown date, but in (b)(6) 2022, a pseudoaneurysm was observed at the distal end of the ctagac.On (b)(6) 2022 reintervention was performed to treat the pseudoaneurysm.A gore® tag® conformable thoracic stent graft with active control system (ctagac) #tgmr313120j, was implanted distally.A proximal type i endoleak of tgmr313120j was observed.To treat it, additionally gore® tag® conformable thoracic stent graft with active control system (ctagac) #tgm343415j, was implanted proximally.A minor proximal type i endoleak remained at an outer curvature.The physician decided to monitor it.The patient tolerated the procedure.((b)(4)) on (b)(6) 2022, new pseudoaneurysm was observed at the distal end of the ctagac #tgm313120j.On (b)(6) 2022, the pseudoaneurysm ruptured.Unable to treat, the patient passed away.The physician stated that he thought that the device, tgm313120j, was the right size, but the cause was unknown.Reportedly, a semi-emergency thoracic endovascular aortic repair was scheduled for (b)(6) 2022.
 
Manufacturer Narrative
Emdr section h6 codes were updated to reflect the result(s) of the investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
samir kulovic
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15597982
MDR Text Key301713254
Report Number2017233-2022-03403
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/13/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberTGMR313120J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age76 YR
Patient SexMale
-
-